Labixiaoxin Snacks Group Ltd (1262) fair value: what the stock is really worth
As of Sep 30, 2026: fair value of Labixiaoxin Snacks Group Ltd HK$0.90, price HK$3.22, upside -72.0%, quality 39 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Labixiaoxin Snacks Group Ltd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.
How to read this chart
60‑month range HK$1.05 – HK$5.50 · fair‑value band HK$0.6290 – HK$1.17 · the HK$3.22 price screens above the HK$0.9010 fair value. Dashed = 300-day average. As of Sep 27, 2026.
Follow Labixiaoxin Snacks Group in your weekly email
Every Wednesday you see whether Labixiaoxin Snacks Group is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Labixiaoxin Snacks Group Limited, an investment holding company, manufactures and sells jelly, confectionary, beverage, and other snack products in the People's Republic of China.
Show more
Labixiaoxin Snacks Group Limited, an investment holding company, manufactures and sells jelly, confectionary, beverage, and other snack products in the People's Republic of China. It offers jelly snacks, such as fruit-flavored, canned fruit, yogurt, and mousse jellies; jelly beverages; lollipops, milk and gummy candies, and chocolates; fruit and vegetable beverages; and powdered milk tea, dried bean curd, and baked products under the Labixiaoxin, Sunshine City, Humor, and Xiangdoufang brands. The company was formerly known as China Lifestyle Food and Beverages Group Limited and changed its name to Labixiaoxin Snacks Group Limited in June 2012. Labixiaoxin Snacks Group Limited was founded in 2000 and is headquartered in Jinjiang, the People's Republic of China.
Stock analysis
Labixiaoxin Snacks Group Ltd (1262) currently trades at HK$3.22, while our model-based Fair Value estimate is HK$0.9010, 72.0% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of HK$1.22 per share, and 1 of the 14 models we run sit above the HK$3.22 price.
Bear case: the Earnings-Based group reads lowest at HK$0.3500, and 13 of the 14 models stay below the price. Evidence for this calculation is low.
Scenario range: HK$0.6290 (bear) to HK$1.17 (bull), the price of HK$3.22 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 39/100 (below-average quality), in the Consumer Defensive sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Labixiaoxin Snacks Group Ltd reported revenue of 970M CNY in FY2025 versus 648M CNY in FY2021, a compound +10.6%/yr. Reported net income was 11.9M CNY in FY2025.
Key figures
Market cap HK$702M (≈ $89.5M) · P/E ratio 40.2 · P/S ratio 0.49 · EPS (TTM) HK$0.0100 · Net margin 1.2% · Return on equity 5.4% · Return on assets (EBIT) −3.3% · Operating margin 4.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 30% below its 52-week high and 103% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at 3% fair-value upside, at −72%, 1262 screens richer than that median.
Fair Value models
Bear HK$0.6290Fair Value HK$0.9010Bull HK$1.17
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (HK$0.0075 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.58/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+11.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.8%
Start year 2020 (pandemic). Over 10 years: −0.8% a year
Revenue growth 23 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.9%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
Compare Labixiaoxin Snacks Group Ltd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Packaged Foods · 641 stocks
Beats the industry median on 2/11 measures
Overall it trails its industry peers.
Valuation
Quality Score39 · Bottom 25%
Fair Value upside−72.0% · Bottom 25%
Profitability
Return on equity (TTM)5.4% · Below median
Return on assets2.5% · Below median
Net margin (TTM)1.2% · Below median
Operating margin (TTM)4.7% · Below median
Growth and dividend
Revenue growth21.7% · Top 25%
Valuation Multiplesvs Packaged Foods median · lower = cheaper
P/E (TTM)40.2× · Priciest 25%
P/B2.65× · Pricier than median
P/S (TTM)0.62× · Cheaper than median
EV/EBITDA8.6× · Pricier than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 32
FUTURE (revenue growth)100· sector 19
PAST (return on equity)22· sector 30
HEALTH (low debt)100· sector 96
DIVIDEND (yield)0· sector 57
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Labixiaoxin Snacks Group Ltd Fair Value". https://www.fairvalue-calculator.com/stock/1262
Frequently asked questions
Is Labixiaoxin Snacks Group Ltd (1262) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of HK$0.9010 versus a price of HK$3.22, about −72% upside (overvalued).
What is the fair value of 1262?
Our model-based fair value for Labixiaoxin Snacks Group Ltd is HK$0.9010 (as of Sep 27, 2026), built from audited fundamentals. The current price: HK$3.22.
What is the quality score of 1262?
Labixiaoxin Snacks Group Ltd has a Quality Score of 39/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Labixiaoxin Snacks Group Ltd (1262)?
Our model-based price target is the fair value of HK$0.9010 (as of Sep 27, 2026) from 14 valuation models. Cautious scenario HK$0.6290, optimistic scenario HK$1.17. It is a calculation from audited fundamentals, not an analyst target.
What is the Labixiaoxin Snacks Group Ltd stock forecast for 2026?
Our models put fair value at HK$0.9010, about −72% upside versus a price of HK$3.22 (overvalued). Cautious scenario HK$0.6290, optimistic scenario HK$1.17. The calculation is refreshed regularly with new filings.
What is the revenue of Labixiaoxin Snacks Group Ltd (1262)?
Labixiaoxin Snacks Group Ltd reported trailing-twelve-month revenue of about 970M CNY (latest available figure, as of Sep 27, 2026).
What is the intrinsic value of Labixiaoxin Snacks Group Ltd (1262)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Labixiaoxin Snacks Group Ltd it is HK$0.9010 per share (as of Sep 27, 2026), against a price of HK$3.22. It is the blended result of 14 valuation models (cash flow, earnings, asset, dividend).
Is Labixiaoxin Snacks Group Ltd stock overvalued or undervalued in 2026?
As of Sep 27, 2026, 1262 trades above its calculated fair value: price HK$3.22, fair value HK$0.9010, a gap of about −72% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 1262?
No. The price is what the market pays today (HK$3.22); the fair value is what the company's own numbers justify (HK$0.9010). For Labixiaoxin Snacks Group Ltd the two are HK$2.31 per share apart. That gap is exactly why we show both numbers side by side.
How much is Labixiaoxin Snacks Group Ltd worth?
The market values Labixiaoxin Snacks Group Ltd at about HK$702M (market capitalisation, as of Sep 27, 2026). Per share that is HK$3.22; our models calculate a fair value of HK$0.9010 per share.
What do the bullish and bearish scenarios say about 1262?
Our models span a range for Labixiaoxin Snacks Group Ltd: cautious scenario HK$0.6290, base HK$0.9010, optimistic HK$1.17 per share (as of Sep 27, 2026, price HK$3.22). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 1262?
Labixiaoxin Snacks Group Ltd trades at a price-to-earnings ratio of 40.2 (as of Sep 27, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of HK$0.9010 is built from several models across several years. Other multiples: P/B 2.7, P/S 0.6, EV/EBITDA 8.6.
How solid is the balance sheet of Labixiaoxin Snacks Group Ltd (1262)?
Balance-sheet figures for Labixiaoxin Snacks Group Ltd (as of Sep 27, 2026): return on equity 5.4%. They feed the Quality Score of 39/100, which measures business quality independently of the share price.
How far is 1262 from its 52-week high?
Labixiaoxin Snacks Group Ltd trades at HK$3.22, about 30% below its 52-week high of HK$4.62 and 103% above the low of HK$1.58 (as of Sep 30, 2026). Distance from the high says nothing about value: that is what the fair value of HK$0.9010 is for.
Which stocks are comparable to Labixiaoxin Snacks Group Ltd?
From the same area (Consumer Defensive) we also value Nestlé S.A, Danone S.A, Foshan Haitian Flavouring and Food Company, The Kraft Heinz Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Labixiaoxin Snacks Group Ltd stock attractive at the current price?
The data as of Sep 27, 2026: price HK$3.22, calculated fair value HK$0.9010 (−72%), Quality Score 39/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 1262 calculated?
We run Labixiaoxin Snacks Group Ltd through 14 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of HK$0.9010, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.7 % above its aggregate fair value. Labixiaoxin Snacks Group Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Labixiaoxin Snacks Group Ltd (1262)?
The closing price on Sep 30, 2026 was HK$3.22. Our model-based fair value is HK$0.9010, about −72% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Labixiaoxin Snacks Group Ltd right now?
The price sits above even our optimistic bull case (HK$1.17). The favourable scenario is already priced in. Weak quality (39/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (HK$0.6290 to HK$1.17) leaves room in how you read the outcome.
Key figures of Labixiaoxin Snacks Group Ltd
How large is the market capitalisation of Labixiaoxin Snacks Group Ltd (1262)?
The market capitalisation of Labixiaoxin Snacks Group Ltd is HK$702M (≈ $89.5M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Labixiaoxin Snacks Group Ltd (1262)?
The price-to-sales ratio of Labixiaoxin Snacks Group Ltd is 0.49 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Labixiaoxin Snacks Group Ltd (1262)?
Earnings per share at Labixiaoxin Snacks Group Ltd are HK$0.0100 (price ÷ EPS = P/E 40.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Labixiaoxin Snacks Group Ltd (1262)?
The net margin of Labixiaoxin Snacks Group Ltd is 1.2% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Labixiaoxin Snacks Group Ltd (1262)?
The return on equity (ROE) of Labixiaoxin Snacks Group Ltd is 5.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Labixiaoxin Snacks Group Ltd (1262)?
On an EBIT basis the return on assets of Labixiaoxin Snacks Group Ltd is −3.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Labixiaoxin Snacks Group Ltd (1262)?
The operating margin of Labixiaoxin Snacks Group Ltd is 4.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Labixiaoxin Snacks Group Ltd (1262)?
Revenue at Labixiaoxin Snacks Group Ltd is growing +21.7% versus a year earlier (3y avg +12.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Labixiaoxin Snacks Group Ltd (1262) generate?
The free cash flow of Labixiaoxin Snacks Group Ltd is −50.6M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Labixiaoxin Snacks Group Ltd (1262) carry?
The net debt of Labixiaoxin Snacks Group Ltd is 448M CNY (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Labixiaoxin Snacks Group Ltd in the live analysis
One click puts Labixiaoxin Snacks Group Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
